Search Results 1721-1730 of 15439 for Hepatitis b

  1. Phase 1/2 Dose Escalation Study In Patients With Relapsed Or Refractory Waldenstrom's Macroglobulinemia - Mayo Clinic

    Has a positive test for human immunodeficiency virus (HIV-1 or -2) hepatitis C virus (HCV) or hepatitis B surface antigen (HBsAg). Receiving chronic ...

  2. A Study Of GDC-0134 To Determine Initial Safety, Tolerability, And Pharmacokinetic Parameters In Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    Positive for hepatitis C antibody, hepatitis B surface antigen, or human immunodeficiency virus (HIV) antibody. Clinically significant thrombocytopenia ...

  3. A Study Of MPDL3280A (Anti-PD-L1 Antibody) Combined With Carboplatin And Paclitaxel , And With Or Without Bevacizumab, For Patients Who Have Stage IV Non-Squamous Non-Small Cell Lung Cancer - Mayo Clinic

    Active hepatitis B or hepatitis C; Prior treatment with CD137 agonists or immune checkpoint blockade therapies, anti PD1, and anti-PD-L1 therapeutic antibody ...

  4. MAGNITUDE: A Phase 3 Study Of NTLA-2001 In Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) - Mayo Clinic

    * Has hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection * History of active malignancy within 3 years prior to screening * RNA ...

  5. A Study To Compare The Effectiveness, Safety And Tolerability Of P1101 Vs. Anagrelide For Essential Thrombocythemia - Mayo Clinic

    Documented autoimmune disease at screening or in the history (e.g., thyroid dysfunction, hepatitis ... B [HBV] and/or hepatitis C [HCV], at screening); ...

  6. Nausea and vomiting News From Mayo Clinic

    Hepatitis B and Hepatitis C: What's the difference? Hepatitis C · Hepatitis C screening · Hepatitis C: How common is sexual transmission? Hepatitis C: What ...

  7. Liver transplant - Doctors & Departments - Mayo Clinic

    Hepatitis B · Hepatitis C · Hepatocellular carcinoma (HCC) · Hilar cholangiocarcinoma · Liver cancer · Liver disease · Liver hemangioma · Living-donor liver ...

  8. Publications - Yunhong Shu, Ph.D. - Mayo Clinic

    ... B, Mabray M, Feghali J, Sair HI, Narvid J, Lupo JM, Lee J, Stadnik A, Alcazar ... Evaluating histologic differentiation of hepatitis B virus-related ...

  9. A Study Evaluating Tolerability And Efficacy Of Navitoclax In Combination With Ruxolitinib In Subjects With Myelofibrosis - Mayo Clinic

    Subject has chronic active hepatitis B (HBV) or hepatitis C (HCV) requiring treatment. Subject exhibits evidence of other clinically significant ...

  10. Pembrolizumab And Ibrutinib In Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery - Mayo Clinic

    Known history of human immunodeficiency virus (HIV) infection, active infection with hepatitis B virus or hepatitis C virus, or any uncontrolled active systemic ...